ABBV vs MAC · P/E 81, rev $61.16B vs rev $918.2M
AbbVie Inc (ABBV) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. MAC currently screens at market cap $4.41B.
Not investment advice. Open the ABBV and MAC stock pages for the full models.
Not investment advice.